FDA Puts New Lupus Drug on Fast-track
Lupuzor a new lupus drug currently in clinical trials has been put on fast track status by the FDA. It’s been labeled by some as a blockbuster drug for lupus. Two great things about this treatment are that it is not an immune system suppressor and it is trying to have as few side affects as possible. It has the potential to stop the progression of lupus in substantial portion of patients.
Read more about the story on our WordPress blog!